Cardioprotection by cyclosporine A in experimental ischemia and reperfusion - Evidence for a nitric oxide-dependent mechanism mediated by endothelin

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 2, 1997, Pages 535-544

  Massoudy, P ^b   Zahler, S ^c   Kupatt, C ^c   Reder, E ^c   Becker, B F ^a   Gerlach, E ^c  

^a Physiologisches Inst der Univ M   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c NONE

Author keywords

Cyclosporine A; Endothelium; Glutathione; Ischemia and reperfusion; Nitric oxide; Prostacyclin

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; BOSENTAN; CYCLOSPORIN A; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; GLUTATHIONE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY VEIN; DRUG EFFECT; DRUG MECHANISM; GUINEA PIG; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART WORK; ISOLATED HEART; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0031080128     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0297     Document Type: Article

References (26)

1. BECKER BF, MASSOUDY P, PERMANETTER B, RASCHKE P, ZAHLER S, 1993. Mögliche Bedeutung von Sauerstoffradikalen für den Reperfusionsschaden. Z Kardiol 82 (Suppl. 5): 49-58.
2. BRUNNER F, DU TOIT EF, OPIE L, 1992. Endothelin release during ischemia and reperfusion of isolated perfused hearts. J Mol Cell Cardiol 24: 1291-1305.
3. BUNCHMAN TE, BROOKSHIRE CA, 1991. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 88: 310-314.
4. DAGASSAN PH, BREU V, CLOZEL M, CLOZEL JP, 1994. Role of endothelin during reperfusion after ischemia in isolated perfused rat heart. J Cardiovasc Pharmacol 28: 867-874.
5. FRELIN C, GUEDIN D, 1994. Why are circulating levels of endothelin-1 so low? Cardiovasc Res 28: 1613-1622.
6. GARLICK PB, DAVIES MJ, HEARSE DJ, SLATER TF, 1987. Direct detection of free radicals in the reperfused heart using electron spin resonance spectroscopy. Circ Res 61: 757-760.
7. GRIEFF M, LOERTSCHER R, SHOHAIB SA, STEWART DJ, 1993. Cyclosporin-induced elevation in circulating endothelin-1 in patients with solid organ transplants. Transplantation 56: 880-884.
8. GRIFFITHS EJ, HALESTRAP AP, 1993. Protection by cyclosporin A of ischemia/reperfusion induced damage in isolated rat hearts. J Mol Cell Cardiol 24: 1461-1469.
9. HAGAR JM, 1994. Endogenous endothelin-1 impairs endothelium-dependent relaxation after myocardial ischemia and reperfusion. Am J Physiol 267: H1833-H1841.
10. KAGAMU H, SUZUKI T, ARAKAWA M, MITSUI Y, 1994. Low oxygen enhances endothelin-1 (ET-1) production and responsiveness to ET-1 in cultured cardiac myocytes. Biochem Biophys Res Commun 202: 1612-1618.
11. KAHAN BD, 1989. Cyclosporine. N Engl J Med 321: 1725-1738.
12. + exchange in mediating effects of endothelin-1 on normal and ischemic/reperfused hearts. Circ Res 75: 369-378.
13. KIOWSKI W, LINDNER L, STOSCHITZKY K, PFISTERER M, BURCKHARDT D, BURHART F, BÜHLER FR, 1994. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 90: 27-34.
14. KRAUSE SM, LYNCH JJ JR, STABILITO II, WOLTMANN RF, 1994. Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischemic injury following acute coronary artery occlusion in the dog. Cardiovasc Res 28: 1672-1678.
15. KUPATT C, ZAHLER S, SELIGMANN C, MASSOUDY P, BECKER BF, GERLACH E, 1996. Nitric oxide mitigates leukocyte adhesion and vascular permeability changes after myocardial ischemia. J Mol Cell Cardiol 28: 643-654.
16. KUROKAWA T, NONAMI T, KOBAYASHI H, KISHIMOTO W, UCHIDA K, TAGAKI H, SUGIYAMA S, OZAWA T, 1992. Inhibition by cyclosporine of the production of super-oxide radicals. N Engl J Med 324: 840.
17. MASSOUDY P, BECKER BF, GERLACH E, 1994. Bradykinin accounts for improved postischemic function and lowered glutathione release of guinea pig hearts, treated with ACE-inhibitor ramiprilat. J Cardiovasc Pharmacol 23: 632-639.
18. MASSOUDY P, BECKER BF, GERLACH E, 1995. Nitric oxide accounts for postischemic cardioprotection resulting from ACE-inhibition: Indirect evidence for a radical scavenger effect in isolated guinea pig hearts. J Cardiovasc Pharmacol 25: 440-447.
19. MINKES RK, BELLAN JA, SAROYAN RM, KERSTEIN MD, COY DH, MURPHY WA, NOSSMAN BD, MCNAMARA BD, KADOWITZ PJ, 1990. Analysis of cardiovascular responses to endothelin-1 and endothelin-3 in anesthetized cat. J Pharmacol Exp Ther 253: 1118-1125.
20. OHLSTEIN EH, VICKERY L, SAUERMELCH C, WILLETTE RN, 1990. Vasodilation induced by endothelin: Role of EDRF and prostanoids in rat hindquarters. Am J Physiol 259: H1835-H1841.
21. SAKURAI T, YANAGISAWA M, MASAKI T, 1992. Molecular characterization of endothelin receptors. Trends Pharmacol Sci 13: 103-108.
22. SCHERRER U, VISSING SF, MORGAN BJ, ROLLINS JA, TINDALL RSA, RING S, HANSON P, MOHANTY PK, VICTOR RG, 1990. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 323: 693-699.
23. SCHÖLKENS BA, LINZ W, 1991. ACE-Hemmung: Mechanismen einer 'Kardioprotektion' bei akuter Myokardischämie. Klin Wochenschr 60 (Suppl. XXIV): 1-5.
24. SCHREIBER SL, CRABTREE GR, 1992. The mechanism of action of cyclosporin A and FK 506. Immunol Today 13: 136-142.
25. TAKEDA Y, MIYAMORE I, YONEDA T, TAKEDA R, 1993. Increased concentration of endothelin messenger RNA in the mesenteric arteries of cyclosporine-induced hypertensive rats. Am J Hypertens 6: 427-430.
26. YANAGISAWA M, KURIHARA H, KIMURA S, TOMOBE Y, KOBAYASHI M, MITSUI Y, YAZAKI Y, GOTO K, MASAKI T, 1986. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.